Saladax Biomedical
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
116 Research Dr, Bethlehem, Pennsylvania...Phone Number
(610) 419-6731Website
www.saladax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Saladax Biomedical
Saladax Biomedical specializes in developing and manufacturing therapeutic drug monitoring (TDM) assays for essential medications used by psychiatrists and oncologists. Their products ensure that patients receive optimal dosing of life-saving drugs, including clozapine and 5-Fluorouracil. The company aims to enhance patient care through fast and reliable testing solutions, significantly reducing wait times for results. Saladax serves clients in the United States, Canada, Europe, and the Middle East, focusing on improving therapeutic outcomes in mental health and oncology.Explore more
Saladax Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Saladax Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Saladax Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Saladax Biomedical had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Saladax Biomedical
Earning: See what the market has to say on Saladax Biomedical recently announced quarterly report
Funding: Get notified immidiatlly once Saladax Biomedical has new funding data
Check out if Saladax Biomedical is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Saladax Biomedical launches new products
Check if Saladax Biomedical has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Saladax Biomedical as Masked Content
Find more new buyers
Compare Similar Companies to Saladax Biomedical
Compare insights from companies similar to Saladax Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Saladax Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Saladax Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Saladax Biomedical.
Saladax Biomedical financials insights
Gather financial insights about Saladax Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series A
$3.6M
2009
Series B
$7.9M
2010
Series C
$8.4M
2013
Series D
$22.9M
2020
Debt
$150K
Saladax Biomedical Tech Stack
A closer look at the technologies used by Saladax Biomedical
Saladax Biomedical News & Media
Saladax Biomedical Inc. Appoints Regulatory and Quality Expert Ms. Stacie Geffner-Atiya as Director of Regulatory and Quality
Bethlehem, PA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc., a leader in innovative therapeutic drug monitoring (TDM) solutions, is pleased to announce the appointment of Ms. Stacie Geffner-Atiya as Director of Regulatory and Quality. With over 20 years of regulatory experience diagnostics (IVDs) and medical devices, Ms. Geffner-Atiya brings a wealth of expertise in navigating complex global regulatory landscapes. Ms. Geffner-Atiya has successfully led regulatory strategies acrossSaladax Biomedical Inc. Welcomes Dr. Sepideh Fanaei as Country Manager for DACH Region, Supporting EU Expansion and Revenue Growth
Bethlehem, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. is thrilled to announce the appointment of Dr. Sepideh Fanaei as Country Manager for the DACH region, which encompasses Germany, Austria, and Switzerland. This new role signifies a critical step in Saladax’s European expansion strategy, which aims to advance the company’s growth in the EU healthcare market.Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada in a rapid six days. This approval recognizes the vital importance of implementing updated guidelines and using 5-Fluorouracil (5-FU) TDM to ensure patients undergoing cancer treatment with this chemotherapy agent get the proper dose.Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
BETHLEHEM, Pa.--(BUSINESS WIRE)-- #TDM--Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Saladax Biomedical
Sign Up For FreeTo access detailed company insights
Saladax Biomedical specializes in developing and manufacturing therapeutic drug monitoring (TDM) assays for essential medications used by psychiatrists and oncologists. Their products ensure that patients receive optimal dosing of life-saving drugs, including clozapine and 5-Fluorouracil. The company aims to enhance patient care through fast and re... Read More
